Martin & Co. Inc. TN trimmed its holdings in shares of TruBridge, Inc. (NASDAQ:TBRG – Free Report) by 3.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 370,608 shares of the company’s stock after selling 14,098 shares during the period. TruBridge comprises about 1.6% of Martin & Co. Inc. TN’s portfolio, making the stock its 12th largest position. Martin & Co. Inc. TN’s holdings in TruBridge were worth $8,680,000 at the end of the most recent quarter.
A number of other hedge funds have also recently made changes to their positions in TBRG. Legal & General Group Plc purchased a new stake in shares of TruBridge during the second quarter valued at about $26,000. Police & Firemen s Retirement System of New Jersey acquired a new stake in TruBridge in the second quarter worth about $59,000. New York State Common Retirement Fund acquired a new stake in TruBridge in the second quarter worth about $101,000. AlphaQuest LLC grew its stake in shares of TruBridge by 88.7% during the first quarter. AlphaQuest LLC now owns 6,325 shares of the company’s stock worth $174,000 after acquiring an additional 2,974 shares during the last quarter. Finally, Integrated Quantitative Investments LLC acquired a new position in shares of TruBridge during the second quarter valued at about $201,000. 88.64% of the stock is currently owned by hedge funds and other institutional investors.
TruBridge Trading Down 2.3%
Shares of TBRG opened at $21.99 on Friday. TruBridge, Inc. has a 52-week low of $17.71 and a 52-week high of $32.00. The stock has a market cap of $330.05 million, a PE ratio of -26.18 and a beta of 0.57. The firm’s fifty day moving average is $20.31 and its two-hundred day moving average is $21.43. The company has a quick ratio of 1.79, a current ratio of 1.80 and a debt-to-equity ratio of 0.94.
Analyst Ratings Changes
A number of brokerages recently issued reports on TBRG. Weiss Ratings restated a “sell (e+)” rating on shares of TruBridge in a research note on Friday, October 31st. BMO Capital Markets started coverage on shares of TruBridge in a research note on Thursday, November 13th. They set a “market perform” rating and a $19.50 target price on the stock. One analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $25.50.
View Our Latest Report on TruBridge
Insider Activity at TruBridge
In related news, major shareholder Pinetree Capital Ltd. purchased 21,035 shares of the company’s stock in a transaction dated Thursday, November 13th. The stock was acquired at an average cost of $20.41 per share, for a total transaction of $429,324.35. Following the completion of the transaction, the insider directly owned 798,220 shares of the company’s stock, valued at approximately $16,291,670.20. This trade represents a 2.71% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Michael Daughton bought 17,500 shares of the company’s stock in a transaction on Monday, November 17th. The stock was bought at an average price of $20.46 per share, with a total value of $358,050.00. Following the completion of the acquisition, the insider owned 57,492 shares in the company, valued at $1,176,286.32. This represents a 43.76% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last 90 days, insiders have bought 143,890 shares of company stock worth $2,916,126. Insiders own 10.70% of the company’s stock.
TruBridge Profile
TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.
See Also
- Five stocks we like better than TruBridge
- What is a Special Dividend?
- Meta Platforms May Ditch NVIDIA Chips—Here’s Why Investors Care
- How to Calculate Return on Investment (ROI)
- SoFi Technologies: From Fintech Speculation to Profit Engine
- Why Are Stock Sectors Important to Successful Investing?
- Gold to $5,000? What Bank of America and UBS Have to Say
Want to see what other hedge funds are holding TBRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TruBridge, Inc. (NASDAQ:TBRG – Free Report).
Receive News & Ratings for TruBridge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TruBridge and related companies with MarketBeat.com's FREE daily email newsletter.
